Page last updated: 2024-09-03

sri 62-834 and Allergic Encephalomyelitis

sri 62-834 has been researched along with Allergic Encephalomyelitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borel, JF; Chabannes, D; Kovarik, J1
Borel, JF; Chabannes, D; Ryffel, B1

Other Studies

2 other study(ies) available for sri 62-834 and Allergic Encephalomyelitis

ArticleYear
Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
    International journal of immunopharmacology, 1995, Volume: 17, Issue:4

    Topics: Animals; Autoimmune Diseases; Concanavalin A; Corticosterone; Cyclosporine; Dexamethasone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Guinea Pigs; Lymph Nodes; Lymphocyte Activation; Lysophosphatidylcholines; Multiple Sclerosis; Myelin Basic Protein; Phospholipid Ethers; Rats; Rats, Inbred Lew; Tuberculin

1995
SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in
    Journal of autoimmunity, 1992, Volume: 5, Issue:2

    Topics: Animals; Cell Movement; Central Nervous System; Chronic Disease; Cyclosporine; Cyclosporins; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Immunosuppressive Agents; Lymph Nodes; Lymphocytes; Multiple Sclerosis; Phospholipid Ethers; Rats; Rats, Inbred Lew; Recurrence; Remission Induction

1992